Stefania Gelmini
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cancer Genomics and Diagnostics 9
- Cancer, Hypoxia, and Metabolism 8
- Oncology 19
- Chemokine receptors and signaling 7
- Co-authors
- Claudio OrlandoMario PazzagliMario SerioFrancesca MalentacchiPamela PinzaniMichaela LuconiLisa SimiM. Serio
- Journals
- The Journal of Clinical Endocrinology & Metabolism (6 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (5 papers)Clinical Chemistry (4 papers)Clinica Chimica Acta (4 papers)New Biotechnology (3 papers)
- Partner nations
- ItalyGermanyUnited States
In The Last Decade
Stefania Gelmini
77 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 118
- Cancer Research 716
- Endocrinology, Diabetes and Metabolism 430
- Molecular Biology 1.3k
- Oncology 528
- Genetics 202
Countries citing papers authored by Stefania Gelmini
This map shows the geographic impact of Stefania Gelmini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Gelmini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Gelmini more than expected).
Fields of papers citing papers by Stefania Gelmini
This network shows the impact of papers produced by Stefania Gelmini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Gelmini. The network helps show where Stefania Gelmini may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefania Gelmini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 3 | |
| 3 | 2021 | 10 | |
| 4 | 2019 | 30 | |
| 5 | 2016 | 16 | |
| 6 | Anti-miR21 oligonucleotide enhances chemosensitivity of T98G cell line to doxorubicin by inducing apoptosis. | 2015 | 36 |
| 7 | 2014 | 30 | |
| 8 | 2013 | 26 | |
| 9 | 2012 | 17 | |
| 10 | 2012 | 80 | |
| 11 | Effects and kinetics of mitotane in in vitro and in vivo models of adrenocortical carcinoma | 2011 | 1 |
| 12 | 2010 | 48 | |
| 13 | 2010 | 10 | |
| 14 | 2010 | 41 | |
| 15 | 2009 | 66 | |
| 16 | 2009 | 46 | |
| 17 | 2003 | 18 | |
| 18 | 2001 | 28 | |
| 19 | 2000 | 28 | |
| 20 | 2000 | 6 |
About Stefania Gelmini
Stefania Gelmini is a scholar working on Cancer Research, Oncology, Molecular Biology, Physiology and Endocrinology, Diabetes and Metabolism, having authored 79 papers that have together received 2.9k indexed citations. Recurring topics across this work include Molecular Biology Techniques and Applications (14 papers), Telomeres, Telomerase, and Senescence (10 papers), Cancer Genomics and Diagnostics (9 papers), Cancer, Hypoxia, and Metabolism (8 papers), Chemokine receptors and signaling (7 papers), DNA Repair Mechanisms (6 papers), Adrenal and Paraganglionic Tumors (6 papers) and Pituitary Gland Disorders and Treatments (5 papers). The work is most often cited by research in Cancer Research (716 citations), Endocrinology, Diabetes and Metabolism (430 citations), Molecular Biology (1.3k citations), Oncology (528 citations) and Genetics (202 citations). Stefania Gelmini has collaborated with scholars based in Italy, Germany and United States. Frequent co-authors include Claudio Orlando, Mario Pazzagli, Mario Serio, Francesca Malentacchi, Pamela Pinzani, Michaela Luconi, Lisa Simi, M. Serio, Gabriella Barbara Vannelli and Giulia Cantini. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Chemistry and Laboratory Medicine (CCLM), Clinical Chemistry, Clinica Chimica Acta and New Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.